These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1325427)

  • 21. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: a preliminary report.
    Farid IM; Hamza IM; El-Abd DM; Mohyi AM; AbdulLatif MM; Aref AT; Hamza DM
    Arab J Gastroenterol; 2014; 15(3-4):142-7. PubMed ID: 25475758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transforming Growth Factor-β1 as a Predictor for the Development of Hepatocellular Carcinoma: A Nested Case-Controlled Study.
    Watanabe Y; Iwamura A; Shimada YJ; Wakai K; Tamakoshi A; Iso H;
    EBioMedicine; 2016 Oct; 12():68-71. PubMed ID: 27614396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An evaluation of transforming growth factor-beta 1 in diagnosing hepatocellular carcinoma and metastasis].
    Dong ZZ; Yao DF; Zou L; Yao M; Qiu LW; Wu XH; Wu W
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jul; 15(7):503-8. PubMed ID: 17669238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
    Fransvea E; Angelotti U; Antonaci S; Giannelli G
    Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.
    Anscher MS; Peters WP; Reisenbichler H; Petros WP; Jirtle RL
    N Engl J Med; 1993 Jun; 328(22):1592-8. PubMed ID: 8487801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth.
    Senturk S; Mumcuoglu M; Gursoy-Yuzugullu O; Cingoz B; Akcali KC; Ozturk M
    Hepatology; 2010 Sep; 52(3):966-74. PubMed ID: 20583212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β regulates hepatocellular carcinoma progression by inducing Treg cell polarization.
    Shen Y; Wei Y; Wang Z; Jing Y; He H; Yuan J; Li R; Zhao Q; Wei L; Yang T; Lu J
    Cell Physiol Biochem; 2015; 35(4):1623-32. PubMed ID: 25824460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistent aortic dissection and hepatocellular carcinoma with elevated plasma transforming growth factor beta level: possible roles of fibrillin 1 and transforming growth factor beta.
    Takagi H; Manabe H; Sekino S; Kato T; Matsuno Y; Umemoto T
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):462-3. PubMed ID: 15678071
    [No Abstract]   [Full Text] [Related]  

  • 33. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS; Lee HS; Kim TY; Im YH; Park JW; Kim NK; Bang YJ
    Biochem Biophys Res Commun; 2002 Mar; 292(2):383-9. PubMed ID: 11906173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of plasma transforming growth factor-beta in patients with glioblastoma multiforme.
    Hulshof MC; Sminia P; Barten-Van Rijbroek AD; Gonzalez Gonzalez D
    Oncol Rep; 2001; 8(5):1107-10. PubMed ID: 11496325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gene expression of TGF-beta1 and its type II receptor in hepatocellular carcinoma].
    Liu C; Chen S; Ou Q
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):740-2. PubMed ID: 11829941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
    Yasmin Anum MY; Looi ML; Nor Aini AH; Merican I; Wahidah A; Mohd Radzi AH; Nor Azizah A; Othman NH
    Med J Malaysia; 2009 Sep; 64(3):223-7. PubMed ID: 20527273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma transforming growth factor-beta 1 reflects disease status in patients with lung cancer after radiotherapy: a possible tumor marker.
    Kong FM; Washington MK; Jirtle RL; Anscher MS
    Lung Cancer; 1996 Dec; 16(1):47-59. PubMed ID: 9017584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bioactivity of transforming growth factor-beta1 can be regulated via binding to dermal collagens in mink lung epithelial cells.
    Shibuya H; Okamoto O; Fujiwara S
    J Dermatol Sci; 2006 Mar; 41(3):187-95. PubMed ID: 16337361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [TGF beta subtypes in hepatocellular carcinoma].
    Pan Z; Yang B; Liu Y
    Zhonghua Yi Xue Za Zhi; 1998 Aug; 78(8):595-7. PubMed ID: 11038809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.
    Mazzocca A; Fransvea E; Dituri F; Lupo L; Antonaci S; Giannelli G
    Hepatology; 2010 Feb; 51(2):523-34. PubMed ID: 19821534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.